or Try an Advanced Search...

    Dystrophy Stocks List

    Symbol Grade Name % Change
    FULC D Fulcrum Therapeutics, Inc. -0.65
    IONS D Ionis Pharmaceuticals, Inc. -2.37
    TVTX F Travere Therapeutics, Inc. 7.48
    BLUE F bluebird bio, Inc. 0.85
    NBSE F NeuBase Therapeutics, Inc. -1.46
    BMY F Bristol-Myers Squibb Company 0.62
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Biopharmaceutical Medicine Biotechnology Diabetes Disorders Genetic Genealogy Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Hepatitis C Virus Infection Huntington's Disease Lipodystrophy Medical Genetics Muscular Dystrophy Myotonic Dystrophy Rare Diseases Sickle Cell Disease Spinal Muscular Atrophy Thalassemia

    Related ETFs - A few ETFs which own one or more of the above listed Dystrophy stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.16
    MEDX D Horizon Kinetics Medical ETF 5.43
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.52
    WBIY D WBI Power Factor High Dividend ETF 4.39
    XPH D SPDR S&P Pharmaceuticals ETF 4.32
    View all Dystrophy ETFs...
    Compare ETFs
    Compare FTXH to MEDX Compare FTXH to XPH Compare MEDX to WBIY

        Dystrophy Stocks Recent News

        Date Stock Title
        May 7 IONS Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
        May 7 IONS Ionis Pharmaceuticals GAAP EPS of -$0.98 beats by $0.09, revenue of $119M misses by $17.41M
        May 7 IONS Ionis reports first quarter 2024 financial results
        May 7 TVTX Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
        May 7 TVTX Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript
        May 6 TVTX Travere Therapeutics Non-GAAP EPS of $1.51 beats by $2.30, revenue of $41.37M misses by $2.25M
        May 6 TVTX Travere Therapeutics Reports First Quarter 2024 Financial Results
        May 6 BLUE bluebird reports first commercial cell collection for Lyfgenia
        May 6 BMY FDA accepts Bristol Myers application for injected Opdivo
        May 6 IONS Ionis Pharmaceuticals Q1 2024 Earnings Preview
        May 6 IONS Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
        May 6 FULC Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET
        May 6 BLUE bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
        May 6 BLUE bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
        May 6 BMY European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
        May 6 BMY U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
        May 5 TVTX Travere Therapeutics Q1 2024 Earnings Preview
        May 4 BMY Pharma R&D productivity seen improving for the first time in years - Deloitte
        May 4 BMY Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a year ago
        May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Biopharmaceutical Medicine Biotechnology Diabetes Disorders Genetic Genealogy Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Hepatitis C Virus Infection Huntington's Disease Lipodystrophy Medical Genetics Muscular Dystrophy Myotonic Dystrophy Rare Diseases Sickle Cell Disease Spinal Muscular Atrophy Thalassemia
        Dystrophy

        Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

        More about Dystrophy
        Browse All Tags